These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 29985049)
1. Intestinal homeostasis is restored in mice following a period of intestinal growth induced by orally administered Emu Oil. Mashtoub S; Cheah KY; Lymn KA; Howarth GS Exp Biol Med (Maywood); 2018 Jul; 243(11):945-952. PubMed ID: 29985049 [TBL] [Abstract][Full Text] [Related]
2. Emu oil expedites small intestinal repair following 5-fluorouracil-induced mucositis in rats. Mashtoub S; Tran CD; Howarth GS Exp Biol Med (Maywood); 2013 Nov; 238(11):1305-17. PubMed ID: 24047797 [TBL] [Abstract][Full Text] [Related]
3. Orally administered emu oil decreases acute inflammation and alters selected small intestinal parameters in a rat model of mucositis. Lindsay RJ; Geier MS; Yazbeck R; Butler RN; Howarth GS Br J Nutr; 2010 Aug; 104(4):513-9. PubMed ID: 20377926 [TBL] [Abstract][Full Text] [Related]
4. Orally administered emu oil attenuates disease in a mouse model of Crohn's-like colitis. Mitchell CJ; Howarth GS; Chartier LC; Trinder D; Lawrance IC; Huang LS; Mashtoub S Exp Biol Med (Maywood); 2020 Dec; 245(18):1697-1707. PubMed ID: 32903038 [TBL] [Abstract][Full Text] [Related]
5. Emu Oil Combined with Lyprinol™ Reduces Small Intestinal Damage in a Rat Model of Chemotherapy-Induced Mucositis. Mashtoub S; Lampton LS; Eden GL; Cheah KY; Lymn KA; Bajic JE; Howarth GS Nutr Cancer; 2016 Oct; 68(7):1171-80. PubMed ID: 27618153 [TBL] [Abstract][Full Text] [Related]
6. Emu Oil reduces disease severity in a mouse model of chronic ulcerative colitis. Safaeian R; Howarth GS; Lawrance IC; Trinder D; Mashtoub S Scand J Gastroenterol; 2019 Mar; 54(3):273-280. PubMed ID: 30907169 [No Abstract] [Full Text] [Related]
7. Emu Oil and zinc monoglycerolate independently reduce disease severity in a rat model of ulcerative colitis. Mashtoub S; Howarth GS Biometals; 2023 Dec; 36(6):1331-1345. PubMed ID: 37402926 [TBL] [Abstract][Full Text] [Related]
8. Emu oil reduces small intestinal inflammation in the absence of clinical improvement in a rat model of indomethacin-induced enteropathy. Abimosleh SM; Tran CD; Howarth GS Evid Based Complement Alternat Med; 2013; 2013():429706. PubMed ID: 23573127 [TBL] [Abstract][Full Text] [Related]
9. Ghrelin improves intestinal mucosal atrophy during parenteral nutrition: An experimental study. Yamada W; Kaji T; Onishi S; Nakame K; Yamada K; Kawano T; Mukai M; Souda M; Yoshioka T; Tanimoto A; Ieiri S J Pediatr Surg; 2016 Dec; 51(12):2039-2043. PubMed ID: 27832865 [TBL] [Abstract][Full Text] [Related]
10. Emu Oil and Saireito in combination reduce tumour development and clinical indicators of disease in a mouse model of colitis-associated colorectal cancer. Chartier LC; Fujino J; Howarth GS; Freysdottir J; Hardardottir I; Mashtoub S Biomed Pharmacother; 2021 Jun; 138():111478. PubMed ID: 33756155 [TBL] [Abstract][Full Text] [Related]
11. Emu oil increases colonic crypt depth in a rat model of ulcerative colitis. Abimosleh SM; Lindsay RJ; Butler RN; Cummins AG; Howarth GS Dig Dis Sci; 2012 Apr; 57(4):887-96. PubMed ID: 22147247 [TBL] [Abstract][Full Text] [Related]
12. Lyprinol only partially improves indicators of small intestinal integrity in a rat model of 5-fluorouracil-induced mucositis. Torres DM; Tooley KL; Butler RN; Smith CL; Geier MS; Howarth GS Cancer Biol Ther; 2008 Feb; 7(2):295-302. PubMed ID: 18059190 [TBL] [Abstract][Full Text] [Related]
13. Emu Oil Improves Clinical Indicators of Disease in a Mouse Model of Colitis-Associated Colorectal Cancer. Chartier LC; Howarth GS; Lawrance IC; Trinder D; Barker SJ; Mashtoub S Dig Dis Sci; 2018 Jan; 63(1):135-145. PubMed ID: 29214422 [TBL] [Abstract][Full Text] [Related]
18. Dietary emu oil supplementation suppresses 5-fluorouracil chemotherapy-induced inflammation, osteoclast formation, and bone loss. Raghu Nadhanan R; Abimosleh SM; Su YW; Scherer MA; Howarth GS; Xian CJ Am J Physiol Endocrinol Metab; 2012 Jun; 302(11):E1440-9. PubMed ID: 22436700 [TBL] [Abstract][Full Text] [Related]
19. Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats. Washizawa N; Gu LH; Gu L; Openo KP; Jones DP; Ziegler TR JPEN J Parenter Enteral Nutr; 2004; 28(6):399-409. PubMed ID: 15568286 [TBL] [Abstract][Full Text] [Related]
20. Effect of bowel rehabilitative therapy on structural adaptation of remnant small intestine: animal experiment. Zhou X; Li YX; Li N; Li JS World J Gastroenterol; 2001 Feb; 7(1):66-73. PubMed ID: 11819735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]